Bayer Continues to Face About 3,900 Unsettled Yaz, Yasmin Lawsuits
Bayer continues to face nearly 4,000 of Yaz and Yasmin birth control pill claims, after agreeing to pay more than $1.74 billion to settle nearly 18,000 cases.
Tag Archives: Yasmin
-
-
Yasmin Stroke Lawsuit Results in $14M Verdict Against Doctor
An Illinois woman successfully sued her doctor for $14 million for prescribing her Yasmin birth control pills, which she says caused her to suffer a damaging stroke.
-
Yaz, Yasmin Settlements Reached in More than 17,000 Cases: Bayer
Bayer says it has settled about 1,700 Yaz and Yasmin lawsuits, but still faces 4,600 blood clot and other birth control pill injury claims.
-
Yaz, Yasmin Settlements Continue, As Over $1.6B Paid to Resolve Cases
Bayer continues to face thousands of remaining Yaz and Yasmin lawsuits, even after paying $1.6 billion in settlements.
-
Direct-to-Consumer Drug Commercials Often Misleading: Study
Most drug commercials on television are misleading, and some are outright falsehoods, according to the findings of a new study.
-
Vaginal Mesh MDLs Have Grown Into Largest Pending Federal Litigations
More than 30,000 lawsuits are in 6 different federal vaginal mesh MDLs, and two are among the top 3 active MDLs in the U.S.
-
Yaz Blood Clot Settlements Top $1.4B, Thousands of Cases Remain
Bayer has paid out $1.4 billion to settle Yaz and Yasmin lawsuits and still faces thousands of claims.
-
Yasmin, Yaz Death Reports Raise Concerns in Canada
Canadian media is reporting that Yaz and Yasmin birth control pills have been implicated in about two dozen deaths over the last three years.
-
Yaz, Yasmin Gallbladder Settlement Reached to Resolve Lawsuits
Bayer Healthcare has agreed to pay up to $24 million to settle Yaz lawsuits and Yasmin lawsuits brought by women who suffered gallbladder injuries that were allegedly caused by the…
-
Yaz, Yasmin Settlements Hit Bayer Revenues
As an increasing number of agreements are being reached to settle Yasmin and Yaz birth control lawsuits, Bayer indicates that the costs associated with the litigation impacted the drug maker’s…